Enabling Successful Sites: Episode 4, Part Two: Leveraging AI to improve patient recruitment and retention
AI is becoming increasingly prevalent in the healthcare industry and clinical research. For clinical trial recruitment, AI can be extremely helpful in finding potential patient volunteers as well improving overall retention rates.
In part two of this ‘Enabling Successful Sites’ podcast episode on improving patient recruitment and retention, Karen McIntyre, Vice President, Global Site Alliances, Steve Sattik, recently retired, former EVP at Flourish Research and Leslie Ives, Senior Director, Patient Recruitment at Parexel, discuss how we can leverage AI today to improve patient recruitment and retention and how they see AI evolving recruitment practices in the future.
Episode 1: Site feasibility and study start-up challenges
Episode 2: Empowering sites to be more inclusive through cultural sensitivity training
Episode 3: Taking the complexity out of oncology clinical trials
Episode 4: Part 1: Partnering with sites to improve patient recruitment and retention
Related Insights
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Blog
Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)
Mar 7, 2024
Blog
Putting AI to work in your safety program
May 21, 2021
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Video
How early-stage diversity strategies can save time and budget later
Oct 3, 2023
Blog
Increasing trial participation and population diversity in early-phase Alzheimer’s disease drug development
Jan 24, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Related Insights
Whitepaper
AI-powered pharmacovigilance: From reactive reporting to predictive risk
Mar 24, 2025
Blog
Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)
Mar 7, 2024
Blog
Putting AI to work in your safety program
May 21, 2021
Whitepaper
Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
Mar 15, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Blog
Best practices and lessons learned in a challenging IBD study
Jul 19, 2023
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Video
How early-stage diversity strategies can save time and budget later
Oct 3, 2023
Blog
Increasing trial participation and population diversity in early-phase Alzheimer’s disease drug development
Jan 24, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024